OncoSec Medical Inc (ONCSQ)

[James salmon]

Firstly RS is being done for 1reason only and that is to continue being listed on NASDAQ, currently there is no need to issue more shares.

Data is due for breast cancer trial but not until towards the end of the year, although it has been indicated that it could possibly come sooner. Early indication is that this data could be good, which will have positive impact on share price later in the year.

There was no choice but to do this as middle of June was date for stock price to be over $1.